Nexalin Technology (NXL) Gross Margin (2021 - 2026)
Nexalin Technology (NXL) recorded quarterly Gross Margin of 87.85% in Q1 2026, little changed quarter-over-quarter from 87.77% in Q4 2025, and up 2090.0% on a YoY basis from 4.01% in Q1 2025.
Nexalin Technology (NXL) Gross Margin (2021 - 2026) Analysis & Trends
Nexalin Technology's Gross Margin history runs 6 years deep, the most recent figure standing at 87.85% for Q1 2026.
- In Q1 2026, Gross Margin rose 2090.0% year-over-year to 87.85%; the TTM figure through Mar 2026 stood at 81.99% (up 1327.0% YoY), while the FY2025 annual figure was 79.65%, up 134.0% from the prior year.
- Gross Margin was 87.85% for Q1 2026 at Nexalin Technology, roughly flat from 87.77% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 88.36% in Q1 2024 to a low of 64.77% in Q3 2024.
- Historically, Gross Margin has averaged 76.43% across 5 years, with a median of 74.53% in 2023.
- The sharpest annual moves came in 2022 and 2026: Gross Margin sank 2206 bps in 2022, then surged 2090 bps in 2026.
- A 5-year view of Gross Margin shows it stood at 82.13% in 2022, then retreated by 9 bps to 74.53% in 2023, then retreated by 3 bps to 72.42% in 2024, then advanced by 21 bps to 87.77% in 2025, then advanced by 0 bps to 87.85% in 2026.
- The last three Gross Margin figures came in at 87.85% (Q1 2026), 87.77% (Q4 2025), and 78.25% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 78.01% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 62.95% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 38.53% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 43.89% |
| 10 | Nexalin Technology | 7.82 Mn | 5.11 Mn | 13,133.00 | 87.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87.85% |
| Dec 31, 2025 | 87.77% |
| Sep 30, 2025 | 78.25% |
| Jun 30, 2025 | 67.65% |
| Mar 31, 2025 | 66.94% |
| Dec 31, 2024 | 72.42% |
| Sep 30, 2024 | 64.77% |
| Jun 30, 2024 | 73.00% |
| Mar 31, 2024 | 88.36% |
| Dec 31, 2023 | 74.53% |
| Sep 30, 2023 | 83.52% |
| Jun 30, 2023 | 73.62% |
| Mar 31, 2023 | 76.73% |
| Dec 31, 2022 | 82.13% |
| Sep 30, 2022 | 65.65% |
| Jun 30, 2022 | 70.30% |
| Mar 31, 2022 | 85.77% |
| Dec 31, 2021 | 104.19% |
| Sep 30, 2021 | 83.37% |